We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$13.9B
AUM Growth
+$1.06B
Cap. Flow
-$389M
Cap. Flow %
-2.8%
Top 10 Hldgs %
25.44%
Holding
2,969
New
81
Increased
186
Reduced
1,131
Closed
145

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$57.5M
2
MDT icon
Medtronic
MDT
+$24.4M
3
UBER icon
Uber
UBER
+$24M
4
AON icon
Aon
AON
+$15.5M
5
TT icon
Trane Technologies
TT
+$12.6M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$81.9M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$40.8M
3
USIG icon
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
+$33.9M
4
AAPL icon
Apple
AAPL
+$18.9M
5
ATVI
Activision Blizzard
ATVI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 27.1%
2 Financials 12.28%
3 Healthcare 11.96%
4 Consumer Discretionary 11.51%
5 Industrials 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTST
1551
NETSTREIT Corp
NTST
$2.08B
$634K ﹤0.01%
35,500
– –
KRTX
1552
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$633K ﹤0.01%
2,000
-28
-1% -$5.44K
ZUO
1553
DELISTED
Zuora, Inc.
ZUO
$633K ﹤0.01%
67,292
– –
TNK icon
1554
Teekay Tankers
TNK
$2.81B
$631K ﹤0.01%
+12,622
New +$606K
ZETA icon
1555
Zeta Global
ZETA
$7.44B
$630K ﹤0.01%
71,474
– –
AKRO
1556
DELISTED
Akero Therapeutics
AKRO
$630K ﹤0.01%
26,995
– –
WRBY icon
1557
Warby Parker
WRBY
$3.2B
$630K ﹤0.01%
44,685
– –
LGND icon
1558
Ligand Pharmaceuticals
LGND
$5.76B
$628K ﹤0.01%
8,797
– –
PPC icon
1559
Pilgrim's Pride
PPC
$6.57B
$628K ﹤0.01%
22,713
-372
-2% -$9.47K
TRUP icon
1560
Trupanion
TRUP
$1.33B
$626K ﹤0.01%
20,530
– –
SCS
1561
DELISTED
Steelcase
SCS
$625K ﹤0.01%
46,219
-1,848
-4% -$21.9K
LGF.B
1562
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$624K ﹤0.01%
61,225
– –
GOGL
1563
DELISTED
Golden Ocean Group
GOGL
$624K ﹤0.01%
63,916
– –
MDRX
1564
DELISTED
Veradigm Inc. Common Stock
MDRX
$623K ﹤0.01%
59,347
– –
OSW icon
1565
OneSpaWorld
OSW
$2.73B
$620K ﹤0.01%
+43,986
New +$512K
RBA icon
1566
RB Global
RBA
$16B
$619K ﹤0.01%
9,255
-132
-1% -$8.48K
PHR icon
1567
Phreesia
PHR
$780M
$618K ﹤0.01%
26,712
– –
APOG icon
1568
Apogee Enterprises
APOG
$897M
$617K ﹤0.01%
11,557
– –
DNOW icon
1569
DNOW Inc
DNOW
$3.04B
$616K ﹤0.01%
54,417
– –
ECPG icon
1570
Encore Capital Group
ECPG
$2.07B
$615K ﹤0.01%
12,117
– –
AIV
1571
Aimco
AIV
$379M
$613K ﹤0.01%
78,308
– –
NHC icon
1572
National Healthcare
NHC
$3.47B
$612K ﹤0.01%
6,619
– –
CIM
1573
Chimera Investment
CIM
$993M
$610K ﹤0.01%
40,749
– –
SSTK icon
1574
Shutterstock
SSTK
$217M
$608K ﹤0.01%
12,600
– –
MSEX icon
1575
Middlesex Water
MSEX
$1.11B
$608K ﹤0.01%
9,267
– –
61 62
63
64 65

Similar funds

BA
Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

MetLife Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, MetLife Investment Management held 2,969 positions worth $13.9B, up 8.2% from $12.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2023 filing shows 81 new, 186 increased, 1,131 reduced and 145 closed positions. Its largest new stake was Accenture: 178,487 shares worth $62.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $81.9M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2023 buy was Accenture: 178,487 shares worth $62.6M.
  • MetLife Investment Management added most to Medtronic in Q4 2023, an estimated $24.4M increase.
  • MetLife Investment Management's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $81.9M.
  • MetLife Investment Management fully exited iShares Core US Aggregate Bond ETF in Q4 2023, selling an estimated $40.8M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.9B portfolio in Q4 2023.
  • MetLife Investment Management opened 81 new positions and closed 145 in Q4 2023.
  • MetLife Investment Management's portfolio value rose 8.2% quarter-over-quarter to $13.9B.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.